Protein Kinase CK2 in Human Diseases

E-ISSN： 1875-533x|15|19|1870-1886

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.15, Iss.19, 2008-01, pp. : 1870-1886

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Protein kinase CK2 inhibitors: a patent review

By Cozza Giorgio Pinna Lorenzo A Moro Stefano

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 9, 2012-09 ,pp. : 1081-1097

Informa Healthcare

Access to resources Recommend Favorite

The Dark Side of Protein Kinase CK2 Inhibition

Current Medicinal Chemistry, Vol. 18, Iss. 19, 2011-06 ,pp. : 2867-2884

Bentham Science Publishers

Access to resources Recommend Favorite

Protein Kinase CK2 as Regulator of Cell Survival: Implications for Cancer Therapy

Current Cancer Drug Targets, Vol. 4, Iss. 1, 2004-02 ,pp. : 77-84

Bentham Science Publishers

Access to resources Recommend Favorite

ATP Site-Directed Inhibitors of Protein Kinase CK2: An Update

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 11, 2011-06 ,pp. : 1340-1351

Bentham Science Publishers

Access to resources Recommend Favorite

Synthesis and biological evaluation of 2,6-di(furan-3-yl)anthracene-9, 10-dione as an inhibitor of human protein kinase CK2

By Haidar S. Meyers A. Bollacke A. Jose J.

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 70, Iss. 12, 2015-12 ,pp. : 772-776

Govi-Verlag

Access to resources Recommend Favorite